¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"spinal point"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • spinal lemniscus
    ô¼ö¼¶À¯¶ì, ô¼ö¼¶À¯´ë
  • spinal leptomeningitis
    ô¼ö¿¬¼ö¸·¿°
  • spinal meningitis
    ô¼ö¸·¿°
  • spinal meningocele
    ô¼ö¸·Å»Ãâ(Áõ), ô¼ö¸··ù
  • spinal muscular atrophy
    ô¼ö±Ù(À°)À§ÃàÁõ
  • spinal mydriasis
    ô¼öµ¿°øÈ®´ë
  • spinal nerve
    ô¼ö½Å°æ
  • spinal nerve root
    ô¼ö½Å°æ»Ñ¸®, ô¼ö½Å°æ±Ù
  • spinal reflex
    ô¼ö¹Ý»ç
  • spinal root
    ô¼ö½Å°æ»Ñ¸®, ô¼ö½Å°æ±Ù
  • spinal segment
    ô¼öºÐÀý
  • spinal shock
    ô¼ö¼îÅ©
  • spinal sign
    ô¼ö¡ÈÄ
  • spinal stenosis
    ôÃß°üÇùÂø(Áõ), ôÁÖ°üÇùÂø(Áõ)
  • spinal tap
    ôÃßõÀÚ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • spinal vestibular nucleus
    ô¼ö¾È¶ãÇÙ
  • ossification point
    (¢¡ossification center) »ÀµÇ±âÁß½É, °ñÈ­Áß½É
  • point
    Á¡
  • point prevalence
    ½ÃÁ¡À¯º´À²
  • point sampling
    Á¡ÃßÃâ¹ý
  • posterior spinal sclerosis
    µÚô¼ö°æÈ­Áõ
  • progressive spastic spinal paralysis
    ÁøÇà°æÁ÷ô¼ö¸¶ºñ
  • reference point
    ±âÁØÁ¡
  • saturation point
    Æ÷È­Á¡
  • spasmodic spinal paralysis
    (¢¡spastic spinal paralysis) °æÁ÷ô¼ö¸¶ºñ
  • spastic spinal paralysis
    °æÁ÷ô¼ö¸¶ºñ
  • spinal evoked potential
    ô¼öÀ¯¹ßÀüÀ§
  • tender point
    ¾ÐÅëÁ¡, ´©¸§ÅëÁ¡
  • trigger point
    À¯¹ßÁ¡
  • working point
    ÀÛ¿ëÁ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • pressure point
    ¾Ð¹ÚºÎÀ§(äâÚÞÝ»êÈ), ¾ÐÅëÁ¡(äâ÷ÔïÇ)
  • primary focal point
    Á¦ÀÏÃÊÁ¡
  • principal point
    ÁÖÁ¡(ñ«ïÇ) ½ÃÃà(ãÊõî)ÀÇ .
  • principal point
    ÁÖÁ¡
  • radiant point
    ¹æ»çÁ¡
  • range of point
    ¿­Á¡(æïïÇ).
  • reference point
    ±âÁØÁ¡
  • reflection point
    ¹Ý»çÁ¡(ÚãÞÒïÇ).
  • remote point
    ¿øÁ¡(êÀïÇ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • mesiolinguoocclusal point angle
    ±Ù½É¼³±³ÇÕ¸é÷°¢
  • metopic point =metopion
    ÀüµÎÁ¡(îñÔéïÇ).
  • metopic point =metopion
    ÀüµÎ Á¡(îñÔéïÇ).
  • mixed melting point
    È¥À¶Á¡(ûèë×ïÇ).
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • motor point
    ¿îµ¿ Á¡(ê¡ÔÑïÇ).
  • motor point
    ¿îµ¿Á¡(ê¡ÔÑïÇ).
  • mutation, point
    Á¡ µ¹¿¬º¯ÀÌ
  • near point
    ±ÙÁ¡
  • near point of accommodation
    Á¶Àý±ÙÁ¡
  • near point of convergence
    ´«¸ðÀ½±ÙÁ¡, ÆøÁÖ±ÙÁ¡
  • neutral point
    ÁßÈ­Á¡(ñéûúïÇ).
  • neutral point
    ÁßÈ­Á¡
  • nodal point
    °áÀýÁ¡, ÀýÁ¡(ï½ïÇ).
  • nodal point
    ±³Á¡
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
FSHSMA facioscapulohumeral spinal muscular atrophy
OEIS omphalocele, exstrophy, imperforate anus, spinal defects [complex]
PISCES percutaneously inserted spinal cord electrical stimulation
PSMA proximal spinal muscular atrophy
PSP pancreatic spasmolytic peptide; paralytic shellfish poisoning; parathyroid secretory protein; period...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
TrP trigger point
TP turning point
ASIA American Spinal Injury Association
aCSF Artificial cerebral spinal fluid
CSF Cerebral Spinal Fluid
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • mental point
    ÅÎ ³¡ À¶±âÁ¡, ÇÏ¾Ç Á¡
  • mesio-bucco-occlusal point angle
    ±Ù½É Çù ±³ÇÕ¸é ÷°¢
  • mesiobuccal occlusal point angle
    ±Ù½É ÇùÇÕ¸é ÷°¢
  • motor point
    ¿îµ¿ Á¡
  • muscle trigger point
    ±Ù ¹ßÅëÁ¡
  • myofascial trigger point pain
    ±Ù¸· ¹ßÅëÁ¡ ÅëÁõ, ±Ù¸· ¹ßÅëÁ¡ µ¿Åë
  • near point of accommodation
    Á¶Àý ±ÙÁ¡
  • object point
    ¹°Á¡
  • occipital point
    ÈĵÎÁ¡
    À¯µ¹ ÈÄ¿¬¿¡ ÀÖ´Â ¾ÐÅëÁ¡À¸·Î, ½Å°æ ¼è¾àÀÇ ÇÑ ÁõÈÄ. µÎ°³ ½Ã»ó°æÀÇ ÈÄ´Ü.
  • ossification point
    °ñ È­Á¡
  • painful point
    µ¿ÅëÁ¡
  • physiological zero point
    »ý¸®Àû ¿µÁ¡
  • pin-point bleeding
    ÇÉ ¸Ó¸® Å©±âÀÇ ÃâÇ÷
  • point A
    A Á¡
    X¼±Çп¡ À־ µÎºÎ °èÃøÀÇ ¸ñÇ¥Á¡À¸·Î¼­, µÎºÎ Ãø¸é»ó¿¡¼­ °áÁ¤µÈ´Ù. ÄÚ ¾Õ ³¡À¸·ÎºÎÅÍ »ó¾Ç ÀÍ»ó µ¹±â¸ª¿¡ À̸£´Â ±¸ºÎ·¯Áø °ñ ºÎºÐÀÇ °¡Àå µ¹ÃâÇÑ ºÎºÐÀÌ´Ù.
  • point mode
    Á¡ ¹æ½Ä
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
dew-point <meteorology> The temperature at which dew begins to form. It varies with the humidity and temperature of the atmosphere.
Source: Websters Dictionary
(01 Mar 1998)
double-point threshold The least degree of separation of two points applied to the body surface that permits of their being felt as two.
(05 Mar 2000)
incident point The point at which a light ray enters an optical system.
(05 Mar 2000)
incisal point The point located between the incisal edges of the lower central incisors; the graphic projection of the excursions of the incisal point in certain planes is generally used to illustrate the envelope of motion of mandibular movement.
(05 Mar 2000)
isoelectric point <biochemistry> The pH at which a protein carries no net charge. Below the isoelectric point proteins carry a net positive charge, above it a net negative charge. Due to a preponderance of weakly acid residues in almost all proteins, they are nearly all negatively charged at neutral pH. The isoelectric point is of significance in protein purification because it is the pH at which solubility is often minimal and at which mobility in an electrofocusing system is zero (and therefore the point at which the protein will accumulate).
(18 Nov 1997)
isoionic point The pH at which a zwitterion has an equal number of positive and negative charges; in water and in the absence of other solutes, this is the isoelectric point.
(05 Mar 2000)
isosbestic point <physics> In applied spectroscopy, a wavelength at which absorbance of two substances, one of which can be converted into the other, is the same.
(05 Mar 2000)
occipital point The most prominent posterior point on the occipital bone above the inion.
(05 Mar 2000)
o-point <physics> Place where the poloidal magnetic field vanishes in such a way that the nearby flux surfaces are elliptical, for example on the magnetic axis or at the centre of a magnetic island. (See also X-Point.)
(09 Oct 1997)
end point <chemistry> It is the completion point during a titration reaction where there are equal amounts of titrant and whatever is being titrated. It is usually evident by the first perceptible alteration of the colour of an added indicator.
<immunology> It is the most dilute an antibody or antiserum solution can be while still detectably reacting with the antigen.
<statistics> A category of data used to compare the outcome in different arms of a clinical trial. Common endpoints are severe toxicity, disease progression or fall in such surrogate markers as CD4 count, but sometimes death is used as an endpoint.
(08 Mar 2000)
end-point measurement Analytical measurement at the end of a chemical reaction, as opposed to making the measurement while the reaction proceeds.
(05 Mar 2000)
end-point nystagmus A jerky, physiologic nystagmus occurring in a normal individual when attempts are made to fixate a point at the limits of the field of fixation.
Synonym: deviational nystagmus.
(05 Mar 2000)
trigger point A specific point or area where, if stimulated by touch, pain, or pressure, a painful response will be induced.
Synonym: dolorogenic zone, trigger area, trigger zone.
(05 Mar 2000)
triple point The temperature at which all three phases (i.e., solid, liquid, and gas) are in equilibrium; the triple point of water (273.16 K) is a fundamental fixed point in temperature scales.
(05 Mar 2000)
equivalence point In a precipitin reaction, the zone in which neither antibody nor antigen is in excess.
See: precipitation.
Synonym: equivalence point.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á